Member Info for Garydav2

The trend is down. Horrible U/T too on Fridays close. Will continue to fall I think

Buy order set at 78p

I'm not quite sure shares always go back up after exiting the index. Alot of the time they do but dont think the shorts are finished with this yet. Will be another battle to force this down further

RBC CUTS PETROFAC PRICE TARGET TO 108 (170) PENCE - 'SECTOR PERFORM'

Might have a punt here if they drop to mid 80s. Got to wait for capitulation yet.... GLA

Wigwammer look it up on Google. Every day there seems to be a debate on these LSE boards about the U/T trade.
There is a 200k sale showing though

Wigwammer that's just the uncrossing trade.....

Happy with today considering the market is down not a bad performance. I think now the news is out and analysts have had chance to study we hopefully have formed a base to move up. GLA

1st batch bought at 275.2 GLA

This board appears very positive considering the share has fallen from over £11 some 40%. Even last few days. -5%, -3% . Are we going to hold £6 next week.....

When you say AZK do you mean Astra Zeneca? I'm thinking if they were bought say this price then market cap is £475M. Say cash around £150M with Q1 figures. Then effectively you are buying for £325M . Seems cheap.
What is the NAV here?

So their Target Price achieved at £6.69. What next......

They are / were a growing company albeit under pressure to find other revenue streams. They are not going to be buying back shares. They will need the cash to grow, recruit and possibly make acquisitions. Make now doubt they will burn through cash....

I wonder what the price is going to do next week? Got to be some up says soon.....

In the R & D update they said LFT tests were being developed and should be ready by Q2 so around late Summer? Is there much money in these tests? Are PCR tests going to reduce.

Interesting piece I read over on Twitter with the Govenment putting out £12bn tenders for testing etc.
In the R&D update there was also talk of NYCT launching LFT tests?
Also I wonder if they are working on any more acquisitions?

I've read alot of posts on here the last week or so.
Dont agree with the lack of news or communication. The Full year report and R&D update in February was very thorough and laid out alot of their work and plans for 2021. Contracts are very confidential and I am sure are being worked through. Also with Governments involved I'm sure they are subject to NDA'S. As has been stated we should get a full update in April 2021.
The drift in share price is entirely due to sentiment and the vaccines. However it will take the Government until Late Autumn to be vaccinate the population and we dont know how the virus will respond over the next few months. And with other countries around the world still behind the UK testing will be needed well into 2021 and 2022.

Hatchris good post. What do you think to the questions I've posed? Are the annual figures due in April? And do you think we may hear more on contracts soon....

So doing further research the stock is off 45% from recent highs. When are results out? We need news on contracts too, when do we think that may be? Also have been reading about the Megalab 'Moonshot' will they have any involvement here?
Testing need going further is the debate I assume and for how long?
Looking at the graph the shares have been steadily falling week on week surely a bounce back is due soon.....?

The chart is low on all indicators. RSI, MACD, near the bottom bollinger band. 5% down yesterday and another 3% today got to be a bounce soon surely. I've taken 3 positions here at 692,685 and 672. GLA